Global Sunitinib Malate Market: 2018-2024
18-Jul-2018 | Number of pages: 175 | Report Id: BMRC302 | Report Format: | Status: Upcoming

Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Global Sunitinib Malate Market: 2018-2024

Brandessence Market Research is working on a new report titleGlobal Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″. Rising occurrence of pancreatic cancer, the convenience of a less drug therapeutic selections for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the early phases of pancreatic cancer are some key drivers for Global Sunitinib Malate Market.

Scope of Global Sunitinib Malate Market Reports –

 Sunitinib Malate is the small molecule, orally bioavailable malate salt of an indolinone-based multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the Food and Drug Administration (FDA) for the treatment of Carcinoma. Sunitinib Malate is having molecular formula C22H27FN4O2 so molecular weight is 398.482 g/mol. The possible antineoplastic activity of Sunitinib has managed to it being observed as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treatment of Pancreatic Neuroendocrine Tumors, Kidney Cancer and Gastrointestinal Stromal Tumor (GIST).

Mechanism of action of Sunitinib Malate is it prevents cellular signaling by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib Malate also inhibits CD117 (c-KIT), the receptor tyrosine kinase that drives the many gastrointestinal stromal cell tumors. The side effects of Sunitinib Malate are Diarrhea, Heartburn, Hypertension, fatigue, Nausea and Vomiting, skin discoloration, cough, upset stomach, hair loss, fever, abdominal pain, shortness of breath, watery eyes, numbness or tingling of the arms or legs and swelling around the eyes.

Global Sunitinib Malate Market has been segmented on the basis of Application and Geography. On the basis of Application Global Sunitinib Malate Market is classified into Pancreatic Neuroendocrine Tumors, Advanced Kidney Cancer, Gastrointestinal stromal tumor (GIST) and others.

The regions covered in Global Sunitinib Malate Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Sunitinib Malate Market Reports –

Global Sunitinib Malate Market reports cover prominent players like Pfizer, Topcare pharmaceutical Co. Ltd, Nanjing First Pharmaceutical Co. Ltd., J&K Scientific, Target Molecule Corp., Medichem, Biotechnica Pharma Global, Beijing Lunarsun Pharmaceutical Co. LTD, Brawn Laboratories Ltd INDIA, Hetero Drugs Ltd INDIA, Hikma Pharmaceutical plc, Jeil Pharmaceutical Co. Ltd, Natco Pharma LTD, Reliance Life Sciences Pvt. Ltd, Shilpa Medicare Ltd INDIA, Sichuan Xieli Pharmaceutical Co LTD, Synthland Ltd and Teva Pharmaceutical Industries Ltd. 

 Global Sunitinib Malate Market Dynamics –

Rising incidence of pancreatic neuroendocrine tumors, pancreatic cancer is a main driver for the Global Sunitinib Malate Market. Likewise, accessibility of an inadequate number of drug therapeutics for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the initial phases of pancreatic cancer is increasing the demand of Sunitinib Malate in the treatment of pancreatic cancer. Conversely high cost of Sutent is one of the key restraints of the Global Sunitinib Malate Market growth. For 28 capsules of Sutent 37.5mg average cash price is $17,968.99. Some side effects of Sutent such as Hepatotoxicity and Adverse cardiovascular events like heart failure, myocardial infarction and coronary artery bypass grafting have also been reported during clinical trials, which could discourage adoption of the drug. Increase in awareness about the disease and technological expansions are likely to raise the Global Sunitinib Malate Market. Also Rising Prevalence of Cancer, Increase in Pharmaceutical R&D Spending, Rising Healthcare Expenditure and Rising Asian Population will boost the Global Sunitinib Malate Market. Systematic Drugs under Pipeline, Rising Scope for Cancer Therapy and increasing awareness towards Carcinoma are some opportunities in the forecast period for the Global Sunitinib Malate Market.

Global Sunitinib Malate Market Regional Analysis –

North America holds the largest share of Global Sunitinib Malate Market amongst others. It is mainly driven by quickly increasing incidence of pancreatic cancer.  Moreover the incomes of customers and health insurance cover for life-threatening diseases in U.S. are very high which raises the affordability of cancer treatment. In recent years, US Food and Drug Administration (USFDA) has taken initiatives to support the progress of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase therefore hastening the clinical development. Asia-Pacific is likely to grow vastly in the future due to some factors such as high occurrence of cancer, rising awareness regarding cure and treatment of cancer and increasing partnership between public and private areas to offer innovative cancer therapy in the region. The incidence of various types of cancer is much more in developing countries which concentrate these regions as favorable locations to conduct clinical trials. Furthermore the cost of clinical research is less in these regions due to the accessibility of a vast population base and favorable government policies contributing to the cancer drugs market growth in the developing countries.

Key Benefits for Global Sunitinib Malate Market Reports –

  • Global Sunitinib Malate Market report covers in depth historical and forecast analysis.
  • Global Sunitinib Malate Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Sunitinib Malate Market report helps to identify opportunities in market place.
  • Global Sunitinib Malate Market report covers extensive analysis of emerging trends and competitive landscape.

Global Sunitinib Malate Market Segmentation

Global Sunitinib Malate Market: By Application Analysis

  • Pancreatic Neuroendocrine Tumors
  • Advanced Kidney Cancer
  • Gastrointestinal stromal tumor (GIST)
  • Other

Global Sunitinib Malate Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Sunitinib Malate Market 2018-2024

Our 175 pages report provides 87 tables, 75 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Sunitinib Malate Market
  • To receive forecasts of Global Sunitinib Malate Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions 
  • To discover the views of experts in the Global Sunitinib Malate Market sector
  • To determine the forces and factor that influences the market for Global Sunitinib Malate Market: drivers, restraints, opportunities and threats
  • To find out where the Global Sunitinib Malate Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Sunitinib Malate Market: By Region Analysis

 

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(Kg)

Production

(Kg)

Global XX XX XX XX XX XX
North America XX XX XX XX XX XX
Europe XX XX XX XX XX XX
Asia Pacific XX XX XX XX XX XX
Latin America XX XX XX XX XX XX
Middle East & Africa XX XX XX XX XX XX
Global XX XX XX XX XX XX

Source: Brandessence Market Research, 2018

 

Global Sunitinib Malate Market: By Application Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(Kg)

Production

(Kg)

Pancreatic Neuroendocrine Tumors XX XX XX XX XX XX
Advanced Kidney Cancer XX XX XX XX XX XX
Gastrointestinal stromal tumour (GIST) XX XX XX XX XX XX
Other XX XX XX XX XX XX

Source: Brandessence Market Research, 2018

 

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey of Global Sunitinib Malate Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • Pfizer
  • Topcare pharmaceutical Co. Ltd
  • Nanjing First Pharmaceutical Co. Ltd.
  • J&K Scientific
  • Target Molecule Corp.
  • Medichem
  • Biotechnica Pharma Global
  • Beijing Lunarsun Pharmaceutical Co. LTD
  • Brawn Laboratories Ltd INDIA
  • Hetero Drugs Ltd INDIA
  • Hikma Pharmaceutical plc
  • Jeil Pharmaceutical Co. Ltd
  • Natco Pharma LTD
  • Reliance Life Sciences Pvt. Ltd
  • Shilpa Medicare Ltd INDIA
  • Sichuan Xieli Pharmaceutical Co LTD
  • Synthland Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Others

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Sunitinib Malate Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Sunitinib Malate Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Sunitinib Malate Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Sunitinib Malate Market Overview: Quantitative Analysis
    • Global Sunitinib Malate Market Production (Kg), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Sunitinib Malate Market Consumption (Kg), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter – Global Sunitinib Malate Market : by Application
  3. Chapter – Global Sunitinib Malate Market : by Manufacturer
    • Global Sunitinib Malate Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Sunitinib Malate Market Production (Kg), by Manufacturer, 2014 – 2024
    • Global Sunitinib Malate Market Consumption (Kg), Manufacturer, 2014 – 2024
    • Global Sunitinib Malate Market Share (%), by Manufacturer, 2017
    • Global Sunitinib Malate Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Sunitinib Malate Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  4. Chapter – Global Sunitinib Malate Market: Regional Analysis
    • North America
    • North America Global Sunitinib Malate Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Sunitinib Malate Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Sunitinib Malate Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  5. Chapter – Company Profiles
    • Pfizer
      • Overview
      • Financials
      • Product portfolio
      • Global Sunitinib Malate Market Revenue (USD Million), Production     (Kg), Consumption (Kg) and Market Share (%), 2014 – 2017
      • Global Sunitinib Malate Market Share (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Topcare pharmaceutical Co. Ltd
    • Nanjing First Pharmaceutical Co. Ltd.
    • J&K Scientific
    • Target Molecule Corp.
    • Medichem
    • Biotechnica Pharma Global
    • Beijing Lunarsun Pharmaceutical Co. LTD
    • Brawn Laboratories Ltd INDIA
    • Hetero Drugs Ltd INDIA
    • Hikma Pharmaceutical plc
    • Jeil Pharmaceutical Co. Ltd
    • Natco Pharma LTD
    • Reliance Life Sciences Pvt. Ltd
    • Shilpa Medicare Ltd INDIA
    • Sichuan Xieli Pharmaceutical Co LTD
    • Synthland Ltd
    • Teva Pharmaceutical Industries Ltd.
    • Others